Send feedback

ABL1 p.Pro951=

c.2853G>A · rs147254521 · VCV746026

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0165%, mid)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.006GERP -3.2
Overall
CADD1.937PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0165% Middle Eastern · 1/6,060 alleles
Filtering AF 0.00944% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00888%
Overall 0.00899% 145/1,612,978 alleles · ultra-rare
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.0165% 6,060
European (non-Finnish) 0.011% 9,076
Remaining individualsnot grpmax-eligible 0.0096% 10,414
African / African-American 0.00933% 10,720
East Asian 0.00223% 44,860

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ABL1
Protein
p.Pro951=
Coding
c.2853G>A
MANE Select
NM_005157
dbSNP
rs147254521
Type
single nucleotide variant
Location
chr9:130885143 (GRCh38)
Gene constraint
LOEUF 0.19 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 64.68 · 85 PDB
Residue 951
the 'disordered' region; the 'dna-binding' region
Full ABL1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/abl1-p-pro951 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown